Gynecologic Cancer

  • Melissa R. Young
  • Susan A. Higgins
  • William Yuh
  • Nina A. Mayr
Part of the Medical Radiology book series (MEDRAD)


The management of gynecologic cancers has historically been guided by a clinically-oriented staging system, based largely on physical examination and standard imaging studies including CT of the abdomen and pelvis. This has more recently been supplemented by pre-treatment MRI and functional imaging, as well as imaging biomarkers. This chapter will focus on the most common gynecologic malignancies, discussing the clinical, pathological, and treatment-related factors that influence clinical outcome as well as the influence of biomarkers on prognosis.


Apparent Diffusion Coefficient Endometrial Cancer Human Papilloma Virus Figo Staging Myometrial Invasion 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. Aalders J, Abeler V, Kolstad P, Onsrud M (1980) Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma: clinical and histopathologic study of 540 patients. Obstet Gynecol 56(4):419–427PubMedGoogle Scholar
  2. Aarnio M, Mecklin JP, Aaltonen LA, Nystrom-Lahti M, Jarvinen HJ (1995) Life-time risk of different cancers in hereditary non-polyposis colorectal cancer (HNPCC) syndrome. Int J Cancer 64(6):430–433PubMedGoogle Scholar
  3. Abeler VM, Kjorstad KE (1991) Endometrial adenocarcinoma in Norway. A study of a total population. Cancer 67(12):3093–3103. Epub 1991/06/15Google Scholar
  4. Abeler VM, Kjorstad KE (1992) Endometrial adenocarcinoma with squamous cell differentiation. Cancer 69(2):488–495PubMedGoogle Scholar
  5. Akbayir O, Corbacioglu A, Numanoglu C, Guleroglu FY, Ulker V, Akyol A et al (2011) Preoperative assessment of myometrial and cervical invasion in endometrial carcinoma by transvaginal ultrasound. Gynecol Oncol 122(3):600–603 Epub 2011/06/28PubMedGoogle Scholar
  6. Alcazar JL, Errasti T, Zornoza A (2000) Saline infusion sonohysterography in endometrial cancer: assessment of malignant cells dissemination risk. Acta Obstet Gynecol Scand 79(4):321–322PubMedGoogle Scholar
  7. Ali MM, Huang DT, Goplerud DR, Howells R, Lu JD (1996) Radiation alone for carcinoma of the vagina: variation in response related to the location of the primary tumor. Cancer 77(9):1934–1939PubMedGoogle Scholar
  8. Al-Kurdi M, Monaghan JM (1981) Thirty-two years experience in management of primary tumours of the vagina. Br J Obstet Gynaecol 88(11):1145–1150PubMedGoogle Scholar
  9. American College of Obstetricians and Gynecologists. ACOG practice bulletin, clinical management guidelines for obstetrician-gynecologists, number 65, August 2005: management of endometrial cancer. Obstet Gynecol 106(2):413–425Google Scholar
  10. Ansink A (1996) Vulvar squamous cell carcinoma. Semin Dermatol 15(1):51–59PubMedGoogle Scholar
  11. Ansink AC vTH, Aartsen EJ, Heintz AP (1991) Outcome, complications and follow-up in surgically treated squamous cell carcinoma of the vulva 1956-1982. Eur J Obstet Gynecol Reprod Biol 42(2):137–143Google Scholar
  12. Ansink ACKM, De Weger RA, Kleyne JA, Pijpers H, Van Tinteren H, De Kraker EW, Helmerhorst TJ, Heintz AP (1994) Human papillomavirus, lichen sclerosus, and squamous cell carcinoma of the vulva: detection and prognostic significance. Gynecol Oncol 52(2):180–184PubMedGoogle Scholar
  13. Antonsen SL, Jensen LN, Loft A, Berthelsen AK, Costa J, Tabor A et al (2013a) MRI, PET/CT and ultrasound in the preoperative staging of endometrial cancer—a multicenter prospective comparative study. Gynecol Oncol 128(2):300–308 Epub 2012/12/04PubMedGoogle Scholar
  14. Antonsen SL, Loft A, Fisker R, Nielsen AL, Andersen ES, Hogdall E et al (2013b) SUVmax of 18FDG PET/CT as a predictor of high-risk endometrial cancer patients. Gynecol Oncol 129(2):298–303PubMedGoogle Scholar
  15. Arko D, Takac I (2000) High frequency transvaginal ultrasonography in preoperative assessment of myometrial invasion in endometrial cancer. J Ultrasound Med 19(9):639–643 Epub 2000/09/06PubMedGoogle Scholar
  16. Ashman JB, Connell PP, Yamada D, Rotmensch J, Waggoner SE, Mundt AJ (2001) Outcome of endometrial carcinoma patients with involvement of the uterine serosa. Gynecol Oncol 82(2):338–343 Epub 2001/09/05PubMedGoogle Scholar
  17. ASTEC study group, Kitchener H, Swart AM, Qian Q, Amos C, Parmar MK (2009) Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet 373(9658):125–136Google Scholar
  18. Averette HE, Ford JH Jr, Dudan RC, Girtanner RE, Hoskins WJ, Lutz MH (1975) Staging of cervical cancer. Clin Obstet Gynecol 18:215–232Google Scholar
  19. Awwad HK, el Naggar M, Mocktar N, Barsoum M (1986) Intercapillary distance measurement as an indicator of hypoxia in carcinoma of the cervix uteri. Int J Radiat Oncol Biol Phys 12(8):1329–1333 Epub 1986/08/01PubMedGoogle Scholar
  20. Bachtiary B, Schindl M, Pötter R, Dreier B, Knocke TH, Hainfellner JA, Horvat R, Birner P (2003) Overexpression of hypoxia-inducible factor 1alpha indicates diminished response to radiotherapy and unfavorable prognosis in patients receiving radical radiotherapy for cervical cancer. Clin Cancer Res 9(6):2234–2240PubMedGoogle Scholar
  21. Baldinu P, Cossu A, Manca A, Satta MP, Pisano M, Casula M et al (2002) Microsatellite instability and mutation analysis of candidate genes in unselected Sardinian patients with endometrial carcinoma. Cancer 94(12):3157–3168 Epub 2002/07/13PubMedGoogle Scholar
  22. Balleyguier C, Sala E, Da Cunha T, Bergman A, Brkljacic B, Danza F et al (2011) Staging of uterine cervical cancer with MRI: guidelines of the European Society of Urogenital Radiology. Eur Radiol 21(5):1102–1110 Epub 2010/11/11PubMedGoogle Scholar
  23. Belhocine T, De Barsy C, Hustinx R, Willems-Foidart J (2002) Usefulness of (18)F-FDG PET in the post-therapy surveillance of endometrial carcinoma. Eur J Nucl Med Mol Imaging 29(9):1132–1139PubMedGoogle Scholar
  24. Benedetti Panici P, Bellati F, Plotti F, Di Donato V, Antonilli M, Perniola G et al (2008) Neoadjuvant chemotherapy followed by radical surgery in patients affected by vaginal carcinoma. Gynecol Oncol 111(2):307–311. Epub 2008/08/19Google Scholar
  25. Berek JS, Hacker NF (1989) Practical gynecologic oncology, 2nd edn. Williams & Wilkins, PhiladelphiaGoogle Scholar
  26. Berman MLKH, Creasman W, DiSaia P, Bundy B, Blessing J (1984) Survival and patterns of recurrence in cervical cancer metastatic to periaortic lymph nodes (a Gynecologic Oncology Group study). Gynecol Oncol 19(1):8–16PubMedGoogle Scholar
  27. Bhosale P, Peungjesada S, Devine C, Balachandran A, Iyer R (2010) Role of magnetic resonance imaging as an adjunct to clinical staging in cervical carcinoma. J Comput Assist Tomogr 34(6):855–864 Epub 2010/11/19PubMedGoogle Scholar
  28. Binder SW, Huang I, Fu YS, Hacker NF, Berek JS (1990) Risk factors for the development of lymph node metastasis in vulvar squamous cell carcinoma. Gynecol Oncol 37(1):9–16PubMedGoogle Scholar
  29. Bipat S, Glas AS, van der Velden J, Zwinderman AH, Bossuyt PM, Stoker J (2003) Computed tomography and magnetic resonance imaging in staging of uterine cervical carcinoma: a systematic review. Gynecol Oncol 91(1):59–66PubMedGoogle Scholar
  30. Blecharz P, Karolewski K, Bieda T, Klimek M, Pudelek J, Kojs E et al (2008) Prognostic factors in patients with carcinoma of the vulva—our own experience and literature review. Eur J Gynaecol Oncol 29(3):260–263PubMedGoogle Scholar
  31. Boruta DM 2nd, Gehrig PA, Groben PA, Bae-Jump V, Boggess JF, Fowler WC Jr et al (2004) Uterine serous and grade 3 endometrioid carcinomas: is there a survival difference? Cancer 101(10):2214–2221PubMedGoogle Scholar
  32. Bosch FX, Manos MM, Munoz N, Sherman M, Jansen AM, Peto J et al (1995) Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst 87(11):796–802. Epub 1995/06/07Google Scholar
  33. Bouma J, Burger MP, Krans M, Hollema H, Pras E (1994) Squamous cell carcinoma of the vagina: a report of 32 cases. Int J Gynecol Cancer 4(6):389–394PubMedGoogle Scholar
  34. Boyce J, Fruchter R, Kasambilides E, Nicastri AD, Sedlis A, Remy JC (1985) Prognostic factors in carcinoma of the vulva. Gynecol Oncol 20(3):364–377PubMedGoogle Scholar
  35. Brinton LA, Nasca PC, Mallin K, Schairer C, Rosenthal J, Rothenberg R et al (1990) Case-control study of in situ and invasive carcinoma of the vagina. Gynecol Oncol 38(1):49–54PubMedGoogle Scholar
  36. Brinton LA, Berman ML, Mortel R, Twiggs LB, Barrett RJ, Wilbanks GD et al (1992) Reproductive, menstrual, and medical risk factors for endometrial cancer: results from a case-control study. Am J Obstet Gynecol 167(5):1317–1325PubMedGoogle Scholar
  37. Bristow RE, Zahurak ML, Alexander CJ, Zellars RC, Montz FJ (2003) FIGO stage IIIC endometrial carcinoma: resection of macroscopic nodal disease and other determinants of survival. Int J Gynecol Cancer 13(5):664–672PubMedGoogle Scholar
  38. Burger MPHH, Emanuels AG, Krans M, Pras E, Bouma J (1995) The importance of the groin node status for the survival of T1 and T2 vulval carcinoma patients. Gynecol Oncol 57(3):327–334PubMedGoogle Scholar
  39. Burger RA, Monk BJ, Kurosaki T, Anton-Culver H, Vasilev SA, Berman ML et al (1996) Human papillomavirus type 18: association with poor prognosis in early stage cervical cancer. J Natl Cancer Inst 88(19):1361–1368 Epub 1996/10/02PubMedGoogle Scholar
  40. Burghardt E, Hofmann H, Ebner F et al (1989) Magnetic resonance imaging in cervical cancer: a basis for objective classification. Gynecol Oncol 33:61–67PubMedGoogle Scholar
  41. Burri P, Djonov V, Aebersold DM, Lindel K, Studer U, Altermatt HJ, Mazzucchelli L, Greiner RH, Gruber G (2003) Significant correlation of hypoxia-inducible factor-1alpha with treatment outcome in cervical cancer treated with radical radiotherapy. Int J Radiat Oncol Biol Phys 56(2):494–501PubMedGoogle Scholar
  42. Bush RS, Jenkin RDT, Allt WEC (1978) Definitive evidence for hypoxic cells influencing cure in cancer therapy. Br J Cancer 37(Suppl 3):302–306Google Scholar
  43. Callister M, Ramondetta LM, Jhingran A, Burke TW, Eifel PJ (2004) Malignant mixed Mullerian tumors of the uterus: analysis of patterns of failure, prognostic factors, and treatment outcome. Int J Radiat Oncol Biol Phys 58(3):786–796PubMedGoogle Scholar
  44. Carlson JA, Ambros R, Malfetano J, Ross J, Grabowski R, Lamb P et al (1998) Vulvar lichen sclerosus and squamous cell carcinoma: a cohort, case control, and investigational study with historical perspective; implications for chronic inflammation and sclerosis in the development of neoplasia. Hum Pathol 29(9):932–948PubMedGoogle Scholar
  45. Chan JK, Kapp DS, Cheung MK, Osann K, Shin JY, Cohn D et al (2007a) The impact of the absolute number and ratio of positive lymph nodes on survival of endometrioid uterine cancer patients. Br J Cancer 97(5):605–611 Epub 2007/08/02PubMedCentralPubMedGoogle Scholar
  46. Chan JKSV, Pham H, Gu M, Rutgers J, Osann K, Cheung MK, Berman ML (2007b) PJ D. Margin distance and other clinico-pathologic prognostic factors in vulvar carcinoma: a multivariate analysis. Gynecol Oncol 104(3):636–641PubMedGoogle Scholar
  47. Chang SJ, Lee EJ, Kim WY, Yoo SC, Yoon JH, Chang KH et al (2010) Value of sonohysterography in preoperative assessment of myometrial invasion for patients with endometrial cancer. J Ultrasound Med 29(6):923–929PubMedGoogle Scholar
  48. Chang MC, Chen JH, Liang JA, Yang KT, Cheng KY, Kao CH (2012) 18F-FDG PET or PET/CT for detection of metastatic lymph nodes in patients with endometrial cancer: a systematic review and meta-analysis. Eur J Radiol 81(11):3511–3517PubMedGoogle Scholar
  49. Chao A, Tang YH, Lai CH, Chang CJ, Chang SC, Wu TI et al (2013) Potential of an age-stratified CA125 cut-off value to improve the prognostic classification of patients with endometrial cancer. Gynecol Oncol 129(3):500–504 Epub 2013/03/06PubMedGoogle Scholar
  50. Charles-Edwards EM, DeSouza NM (2006) Diffusion-weighted magnetic resonance imaging and its application to cancer. Cancer Imaging 6:135–143Google Scholar
  51. Charles-Edwards EMMC, Morgan VA, De Silva SS, McWhinney NA, Katesmark M, Attygalle AD, DeSouza NM (2008) Diffusion-weighted imaging in cervical cancer with an endovaginal technique: potential value for improving tumor detection in stage Ia and Ib1 disease. Radiology 249(2):541–550PubMedGoogle Scholar
  52. Chenevert TLSL, Taylor JM, Robertson PL, Greenberg HS, Rehemtulla A, Ross BD (2000) Diffusion magnetic resonance imaging: an early surrogate marker of therapeutic efficacy in brain tumors. J Natl Cancer Inst 92(24):2029–2036PubMedGoogle Scholar
  53. Cheng W, Chen C, Lee C (2000) Vascular endothelial growth factor and prognosis in cervical carcinoma. Obstet Gynecol 96:721–726PubMedGoogle Scholar
  54. Chi DS, Welshinger M, Venkatraman ES, Barakat RR (1997) The role of surgical cytoreduction in Stage IV endometrial carcinoma. Gynecol Oncol 67(1):56–60PubMedGoogle Scholar
  55. Choschzick M, Woelber L, Hess S, zu Eulenburg C, Schwarz J, Simon R et al (2010) Overexpression of carbonic anhydrase IX (CAIX) in vulvar cancer is associated with tumor progression and development of locoregional lymph node metastases. Virchows Arch 456(5):483–490Google Scholar
  56. Chung YMKB, Park CS, Huh SJ, Kim J, Park JK, Cho SM, Kim BS, Kim JS, Yoo YD, Bae DS (2005) Increased expression of ICAM-3 is associated with radiation resistance in cervical cancer. Int J Cancer 117(2):194–201PubMedGoogle Scholar
  57. Chung HH, Kim JW, Park NH, Song YS, Kang SB, Lee HP (2006) Use of preoperative serum CA-125 levels for prediction of lymph node metastasis and prognosis in endometrial cancer. Acta Obstet Gynecol Scand 85(12):1501–1505 Epub 2007/01/30PubMedGoogle Scholar
  58. Chung HH, Kang WJ, Kim JW, Park NH, Song YS, Chung JK et al (2008) The clinical impact of [(18)F]FDG PET/CT for the management of recurrent endometrial cancer: correlation with clinical and histological findings. Eur J Nucl Med Mol Imaging 35(6):1081–1088PubMedGoogle Scholar
  59. Chyle V, Zagars G, Wheeler JA, Wharton JT, Delclos L (1996) Definitive radiotherapy for carcinoma of the vagina: outcome and prognostic factors. Int J Radiat Oncol Biol Phys 35(5):191–905Google Scholar
  60. Cohn DE, Dehdashti F, Gibb RK, Mutch DG, Rader JS, Siegel BA et al (2002) Prospective evaluation of positron emission tomography for the detection of groin node metastases from vulvar cancer. Gynecol Oncol 85(1):179–184PubMedGoogle Scholar
  61. Connell PP, Rotmensch J, Waggoner S, Mundt AJ (1999) The significance of adnexal involvement in endometrial carcinoma. Gynecol Oncol 74(1):74–79 Epub 1999/07/01PubMedGoogle Scholar
  62. Connor JP, Andrews JI, Anderson B, Buller RE (2000) Computed tomography in endometrial carcinoma. Obstet Gynecol 95(5):692–696PubMedGoogle Scholar
  63. Cooper RA, Wilks DP, Logue JP, Davidson SE, Hunter RD, Roberts SA et al (1998) High angiogenesis is associated with poor survival in carcinoma of the cervix treated with radiotherapy. Clin Can Res 4:2795–2800Google Scholar
  64. Cormio G, Loizzi V, Carriero C, Cazzolla A, Putignano G, Selvaggi L (2010) Groin recurrence in carcinoma of the vulva: management and outcome. Eur J Cancer Care 19(3):302–307 Epub 2009/10/17Google Scholar
  65. Cosin JAFJ, Chen MD, Paley PJ, Carson LF, Twiggs LB (1998) Pretreatment surgical staging of patients with cervical carcinoma: the case for lymph node debulking. Cancer 82(11):2241–2248PubMedGoogle Scholar
  66. Creasman W (2009) Revised FIGO staging for carcinoma of the endometrium. Int J Gynaecol Obstet 105(2):109PubMedGoogle Scholar
  67. Creasman WTPJ, Menck HR (1998) The National Cancer Data Base report on cancer of the vagina. Cancer 83(5):1033–1040PubMedGoogle Scholar
  68. Creasman WTMC, Bundy BN et al (1987) Surgical pathologic spread patterns of endometrial cancer: a Gynecologic Oncology Group study. Cancer 60:2035–2041PubMedGoogle Scholar
  69. Creutzberg CL vPW, Koper PC, Lybeert ML, Jobsen JJ, Wárlám-Rodenhuis CC, De Winter KA, Lutgens LC, van den Bergh AC, van de Steen-Banasik E, Beerman H, van Lent M (2000) Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma. Lancet 355:1404–1411Google Scholar
  70. Creutzberg CL vPW, Koper PC, Lybeert ML, Jobsen JJ, Wárlám-Rodenhuis CC, De Winter KA, Lutgens LC, van den Bergh AC, van der Steen-Banasik E, Beerman H, van Lent M, PORTEC Study Group (2003) Survival after relapse in patients with endometrial cancer: results from a randomized trial. Gynecol Oncol 89(2):201–209Google Scholar
  71. Creutzberg CL vPW, Wárlám-Rodenhuis CC, van den Bergh AC, de Winter KA, Koper PC, Lybeert ML, Slot A, Lutgens LC, Stenfert Kroese MC, Beerman H, van Lent M (2004) Postoperative Radiation Therapy in Endometrial Carcinoma Trial,. Outcome of high-risk stage IC, grade 3, compared with stage I endometrial carcinoma patients: the Postoperative Radiation Therapy in Endometrial Carcinoma Trial. J Clin Oncol 22(7):1234–1241Google Scholar
  72. Current FIGO (2009) staging for cancer of the vagina, fallopian tube, ovary, and gestational trophoblastic neoplasia. Int J Gynaecol Obstet 105(1):3–4 Google Scholar
  73. Daling JR, Madeleine MM, Schwartz SM, Shera KA, Carter JJ, McKnight B et al (2002) A population-based study of squamous cell vaginal cancer: HPV and cofactors. Gynecol Oncol 84(2):263–270PubMedGoogle Scholar
  74. Dalrymple JL, Russell AH, Lee SW, Scudder SA, Leiserowitz GS, Kinney WK et al (2004) Chemoradiation for primary invasive squamous carcinoma of the vagina. Int J Gynecol Cancer 14(1):110–117 Epub 2004/02/07PubMedGoogle Scholar
  75. Davidson SE, Symonds RP, Lamont D, Watson ER (1989) Does adenocarcinoma of uterine cervix have a worse prognosis than squamous carcinoma when treated by radiotherapy? Gynecol Oncol 33(1):23–26 Epub 1989/04/01PubMedGoogle Scholar
  76. Davis KP, Stanhope CR, Garton GR, Atkinson EJ, O’Brien PC (1991) Invasive vaginal carcinoma: analysis of early-stage disease. Gynecol Oncol 42(2):131–136PubMedGoogle Scholar
  77. de Crevoisier R, Sanfilippo N, Gerbaulet A, Morice P, Pomel C, Castaigne D et al (2007) Exclusive radiotherapy for primary squamous cell carcinoma of the vagina. Radiother Oncol 85(3):362–370 Epub 2007/10/30PubMedGoogle Scholar
  78. de Koning MN, Quint WG, Pirog EC (2008) Prevalence of mucosal and cutaneous human papillomaviruses in different histologic subtypes of vulvar carcinoma. Mod Pathol 21(3):334–344PubMedGoogle Scholar
  79. Del Pino M, Rodriguez-Carunchio L, Ordi J (2013) Pathways of vulvar intraepithelial neoplasia and squamous cell carcinoma. Histopathology 62(1):161–175PubMedGoogle Scholar
  80. Dellas A, Moch H, Schultheiss E, Feichter G, Almendral AC, Gudat F et al (1997) Angiogenesis in cervical neoplasia: microvessel quantitation in precancerous lesions and invasive carcinomas with cliniciopathological correlations. Gynecol Oncol 67:27–33PubMedGoogle Scholar
  81. DelMaschio A, Vanzulli A, Sironi S, Spagnolo D, Belloni C, Garancini P et al (1993) Estimating the depth of myometrial involvement by endometrial carcinoma: efficacy of transvaginal sonography vs MR imaging. Am J Roentgenol 160(3):533–538 Epub 1993/03/01Google Scholar
  82. Dessole S, Rubattu G, Farina M, Capobianco G, Cherchi PL, Tanda F et al (2006) Risks and usefulness of sonohysterography in patients with endometrial carcinoma. Am J Obstet Gynecol 194(2):362–368PubMedGoogle Scholar
  83. Diesche S, Anderson P, Sealy R (1983) Carcinoma of the cervix—anaemia, radiotherapy and hyperbaric oxygen. Br J Radiol 56:251–255Google Scholar
  84. Dinh TV, Hannigan EV, Smith ER et al (1996) Tumor angiogenesis as a predictor of recurrence in stage Ib squamous cell carcinoma of the cervix. Obstet Gynecol 87(5, Part 1):751–754Google Scholar
  85. Dixit S, Singhal S, Baboo HA (1993) Squamous cell carcinoma of the vagina: a review of 70 cases. Gynecol Oncol 48(1):80–87PubMedGoogle Scholar
  86. Dolan JR, McCall AR, Gooneratne S, Walter S, Lansky DM (1993) DNA ploidy, proliferation index, grade, and stage as prognostic factors for vulvar squamous cell carcinomas. Gynecol Oncol 48(2):232–235PubMedGoogle Scholar
  87. Dunst J, Kuhnt T, Strauss HG, Krause U, Pelz T, Koelbl H et al (2003) Anemia in cervical cancers: impact on survival, patterns of relapse, and association with hypoxia and angiogenesis. Int J Radiat Oncol Biol Phys 56(3):778–787PubMedGoogle Scholar
  88. Edge SB, Byrd DR, Compton CC et al (eds) (2009) American Joint Committee on Cancer, American Cancer Society. AJCC Cancer Staging Manual, 7th ed. Springer, Berlin Google Scholar
  89. Eifel PJ (1994) Problems with the clinical staging of carcinoma of the cervix. Semin Radiat Oncol 4:1–8PubMedGoogle Scholar
  90. Eifel PJ, Morris M, Wharton JT, Oswald MJ (1994) The influence of tumor size and morphology on the outcome of patients with FIGO stage IB squamous cell carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 29:9–16PubMedGoogle Scholar
  91. Eifel PJ, Burke TW, Morris M, Smith TL (1995) Adenocarcinoma as an independent risk factor for disease recurrence in patients with stage IB cervical carcinoma. Gynecol Oncol 59(1):38–44 Epub 1995/10/01PubMedGoogle Scholar
  92. Eifel PJ, Winter K, Morris M, Levenback C, Grigsby PW, Cooper J et al (2004) Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01. J Clin Oncol 22(5):872–880 Epub 2004/03/03PubMedGoogle Scholar
  93. Eltabbakh GH (2002) Analysis of survival after laparoscopy in women with endometrial carcinoma. Cancer 95(9):1894–1901PubMedGoogle Scholar
  94. Eltabbakh GH, Moore AD (1999) Survival of women with surgical stage II endometrial cancer. Gynecol Oncol 74(1):80–85PubMedGoogle Scholar
  95. Evans J, Bergsjo P (1965) The influence of anemia and results of radiotherapy in carcinoma of the cervix. Radiology 48:709–717Google Scholar
  96. Farley JH, Hickey KW, Carlson JW, Rose GS, Kost ER, Harrison TA (2003) Adenosquamous histology predicts a poor outcome for patients with advanced-stage, but not early-stage, cervical carcinoma. Cancer 97(9):2196–2202 Epub 2003/04/25PubMedGoogle Scholar
  97. Faul CM, Mirmow D, Huang Q, Gerszten K, Day R, Jones MW (1997) Adjuvant radiation for vulvar carcinoma: improved local control. Int J Radiat Oncol Biol Phys 38(2):381–389 Epub 1997/05/01PubMedGoogle Scholar
  98. Ferrandina G, Ranelletti FO, Gallotta V, Martinelli E, Zannoni GF, Gessi M et al (2005) Expression of cyclooxygenase-2 (COX-2), receptors for estrogen (ER), and progesterone (PR), p53, ki67, and neu protein in endometrial cancer. Gynecol Oncol 98(3):383–389 Epub 2005/06/28PubMedGoogle Scholar
  99. Finan MA, Barre G (2003) Bartholin’s gland carcinoma, malignant melanoma and other rare tumours of the vulva. Best Pract Res Clin Obstet Gynaecol 17(4):609–633PubMedGoogle Scholar
  100. Flueckiger F, Ebner F, Poschauko H, Tamussino K, Einspieler R (1992) G. R. Cervical cancer: serial MR imaging before and after primary radiation therapy—a 2-year follow-up study. Radiology 184:89–93PubMedGoogle Scholar
  101. Fons G, Burger MP, Ten Kate FJ, van der Velden J (2007) Identification of potential prognostic markers for vulvar cancer using immunohistochemical staining of tissue microarrays. Int J Gynecol Pathol 26(2):188–193PubMedGoogle Scholar
  102. Fons G, Hyde SE, Buist MR, Schilthuis MS, Grant P, Burger MP et al (2009a) Prognostic value of bilateral positive nodes in squamous cell cancer of the vulva. Int J Gynecol Cancer 19(7):1276–1280PubMedGoogle Scholar
  103. Fons G, Hyde S, Buist MR, Schilthuis MS, Grant P, Burger MP, van der Velden J (2009b) Prognostic value of bilateral positive nodes in squamous cell cancer of the vulva. Int J Gynecol Cancer 19(7):1276–1280Google Scholar
  104. Frank SJJA, Levenback C, Eifel PJ (2005) Definitive radiation therapy for squamous cell carcinoma of the vagina. Int J Radiat Oncol Biol Phys 62(1):138–147PubMedGoogle Scholar
  105. Frank SJDM, Jhingran A, Bodurka DC, Eifel PJ (2007) Primary adenocarcinoma of the vagina not associated with diethylstilbestrol (DES) exposure. Gynecol Oncol 105(2):470–474PubMedGoogle Scholar
  106. Franklin EW 3rd (1972) Clinical staging of carcinoma of the vulva. Obstet Gynecol 40(3):277–286PubMedGoogle Scholar
  107. Gaffney DK, Haslam D, Tsodikov A, Hammond E, Seaman J, Holden J et al (2003) Epidermal growth factor receptor (EGFR) and vascular andothelial factor receptor (VGEF) negatively affect overall survival in carcinoma of the cervix treated with radiotherapy. Int J Rad Oncol Biol Phys 56:922–928Google Scholar
  108. Galic V, Herzog TJ, Lewin SN, Neugut AI, Burke WM, Lu YS et al (2012) Prognostic significance of adenocarcinoma histology in women with cervical cancer. Gynecol Oncol 125(2):287–291 Epub 2012/01/24PubMedGoogle Scholar
  109. Geisinger KR, Marshall RB, Kute TE, Homesley HD (1986) Correlation of female sex steroid hormone receptors with histologic and ultrastructural differentiation in adenocarcinoma of the endometrium. Cancer 58(7):1506–1517 Epub 1986/10/01PubMedGoogle Scholar
  110. Gonzalez Bosquet J, Kinney W, Russell AH, Gaffey TA, Magrina JF, Podratz KC (2003) Risk of occult inguinofemoral lymph node metastasis from squamous carcinoma of the vulva. Int J Radiat Oncol Biol Phys 57(2):419–424Google Scholar
  111. Gordinier ME, Steinhoff MM, Hogan JW, Peipert JF, Gajewski WH, Falkenberry SS et al (1997) S-Phase fraction, p53, and HER-2/neu status as predictors of nodal metastasis in early vulvar cancer. Gynecol Oncol 67(2):200–202PubMedGoogle Scholar
  112. Greco A, Mason P, Leung AWL, Dische S, McIndoe GA, Anderson MC (1989) Staging of carcinoma of the uterine cervix: MRI-surgical correlation. Clin Radiol 40(4):401–405. Epub JulyGoogle Scholar
  113. Greven KM, Curran WJ Jr, Whittington R, Fanning J, Randall ME, Wilder J et al (1989) Analysis of failure patterns in stage III endometrial carcinoma and therapeutic implications. Int J Radiat Oncol Biol Phys 17(1):35–39 Epub 1989/07/01PubMedGoogle Scholar
  114. Grisaru D, Covens A, Chapman B, Shaw P, Colgan T, Murphy J et al (2001) Does histology influence prognosis in patients with early-stage cervical carcinoma? Cancer 92(12):2999–3004 Epub 2001/12/26PubMedGoogle Scholar
  115. Grogan M, Thomas GM, Melamed I, Wong FLW, Pearcey RG, Joseph PK et al (1999) The importance of hemoglobin levels during radiotherapy for carcinoma of the cervix. Cancer 86:1528–1536PubMedGoogle Scholar
  116. Grossman J, Ricci ZJ, Rozenblit A, Freeman K, Mazzariol F, Stein MW (2008) Efficacy of contrast-enhanced CT in assessing the endometrium. Am J Roentgenol 191(3):664–669Google Scholar
  117. Growdon WB, Boisvert SL, Akhavanfard S, Oliva E, Dias-Santagata DC, Kojiro S et al (2008) Decreased survival in EGFR gene amplified vulvar carcinoma. Gynecol Oncol 111(2):289–297PubMedGoogle Scholar
  118. Gustafson S, Zbuk KM, Scacheri C, Eng C (2007) Cowden syndrome. Semin Oncol 34(5):428–434PubMedGoogle Scholar
  119. Hacker NF (2009) Revised FIGO staging for carcinoma of the vulva. Int J Gynaecol Obstet 105(2):105–106PubMedGoogle Scholar
  120. Hacker NF, Berek JS, Lagasse LD, Leuchter RS, Moore JG (1983) Management of regional lymph nodes and their prognostic influence in vulvar cancer. Obstet Gynecol 61(4):408–412Google Scholar
  121. Haensgen G, Krause U, Becker A, Stadler P, Lautenschlaeger C, Wohlrab W, Rath FW, Molls M, Dunst J (2001) Tumor hypoxia, p53, and prognosis in cervical cancers. Int J Radiat Oncol Biol Phys 50(4):865–872PubMedGoogle Scholar
  122. Hamstra DA, Rehemtulla A, Ross BD (2008) Diffusion magnetic resonance imaging: a biomarker for treatment response in oncology. J Clin Oncol 25:4104–4109Google Scholar
  123. Hantschmann P, Jeschke U, Friese K (2005) TGF-alpha, c-erbB-2 expression and neoangiogenesis in vulvar squamous cell carcinoma. Anticancer Res 25(3A):1731–1737PubMedGoogle Scholar
  124. Harima Y, Harima K, Shikata N, Oka A, Ohnishi T, Tanaka Y (1998) Bax and Bcl-2 expressions predict response to radiotherapy in human cervical cancer. J Cancer Res Clin Oncol 124(9):503–510PubMedGoogle Scholar
  125. Harima Y, Sawada S, Miyazaki Y, Kin K, Ishihara H, Imamura M, Sougawa M, Shikata N, Ohnishi T (2003) Expression of Ku80 in cervical cancer correlates with response to radiotherapy and survival. Am J Clin Oncol 26(4):e80–e85PubMedGoogle Scholar
  126. Harima Y, Togashi A, Horikoshi K (2004) Prediction of outcome of advanced cervical cancer to thermoradiotherapy according to expression profiles of 35 genes selected by cDNA microarray analysis. Int J Radiat Oncol Biol Phys 60:237–248PubMedGoogle Scholar
  127. Harry VNSS, Gilbert FJ, Parkin DE (2008) Diffusion-weighted magnetic resonance imaging in the early detection of response to chemoradiation in cervical cancer. Gynecol Oncol 111:213–220PubMedGoogle Scholar
  128. Hatano K, Sekiya Y, Araki H, Sakai M, Togawa T, Narita Y et al (1999) Evaluation of the therapeutic effect of radiotherapy on cervical cancer using magnetic resonance imaging. Int J Radiat Oncol Biol Phys 45:639–644Google Scholar
  129. Hawighorst H, Knapstein PG, Weikel W, Knopp MV, Zuna I, Knof A et al (1997) Angiogenesis of uterine cervical carcinoma: characterization by pharmacokinetic magnetic resonance parameters and histological microvessel density with correlation to lymphatic involvement. Cancer Res 57:4777–4786PubMedGoogle Scholar
  130. Hawighorst H, Weikel W, Knapstein PG et al (1998) Angiogenic activity of cervical carcinoma: assessment by functional magnetic resonance imaging-based parameters and a histomorphological approach in correlation with disease outcome. Clin Cancer Res 4(10):2305–2312PubMedGoogle Scholar
  131. Heaps JM, Fu YS, Montz FJ, Hacker NF, Berek JS (1990) Surgical-pathologic variables predictive of local recurrence in squamous cell carcinoma of the vulva. Gynecol Oncol 38(3):309–314PubMedGoogle Scholar
  132. Hefler L, Mayerhofer K, Leibman B, Obermair A, Reinthaller A, Kainz C et al (2000) Tumor anemia and thrombocytosis in patients with vulvar cancer. Tumour Biol 21(5):309–314PubMedGoogle Scholar
  133. Hefler LA, Grimm C, Six L, Seebacher V, Polterauer S, Joura E et al (2008) Inguinal sentinel lymph node dissection vs. complete inguinal lymph node dissection in patients with vulvar cancer. Anticancer Res 28(1B):515–517. Epub 2008/04/04Google Scholar
  134. Hildesheim A, Han CL, Brinton LA, Kurman RJ, Schiller JT (1997) Human papillomavirus type 16 and risk of preinvasive and invasive vulvar cancer: results from a seroepidemiological case-control study. Obstet Gynecol 90(5):748–754PubMedGoogle Scholar
  135. Hirai Y, Fujimoto I, Yamauchi K, Hasumi K, Masubuchi K, Sano Y (1989) Peritoneal fluid cytology and prognosis in patients with endometrial carcinoma. Obstet Gynecol 73(3 Pt 1):335–338PubMedGoogle Scholar
  136. Hansgen G hK, Dunst J (1996) Oxygen status of cervical cancer prior and during definitive radiotherapy: possible impact of pretreatment with INF-a-2a-Retinol acid on oxygenation (abstr). Int J Radiat Oncol Biol Phys 36(Suppl):324Google Scholar
  137. Hockel M, Schlenger K, Aral B, Mitze M, Schaffer U (1996) P V. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res 56:4509–4515PubMedGoogle Scholar
  138. Hoffmann G, Casper F, Weikel W, Kummerle T, Pollow B, Schaffrath M et al (1999) Value of p53, urokinase plasminogen activator, PAI-1 and Ki-67 in vulvar carcinoma. Zentralbl Gynakol 121(10):473–478. Untersuchungen zu p53, UPA, PAI-1 und Ki-67 beim VulvakarzinomGoogle Scholar
  139. Hogberg T, Signorelli M, de Oliveira CF, Fossati R, Lissoni AA, Sorbe B et al (2010) Sequential adjuvant chemotherapy and radiotherapy in endometrial cancer—results from two randomised studies. Eur J Cancer 46(13):2422–2431PubMedCentralPubMedGoogle Scholar
  140. Holcomb K, Delatorre R, Pedemonte B, McLeod C, Anderson L, Chambers J (2002) E-cadherin expression in endometrioid, papillary serous, and clear cell carcinoma of the endometrium. Obstet Gynecol 100(6):1290–1295 Epub 2002/12/07PubMedGoogle Scholar
  141. Homesley H, Raben M, Blake D (1980) Relationship of lesion size to survival in patients with stage IB squamous cell carcinoma of the cervix uteri treated by radiation therapy. Surg Gynecol Obstet 150:529–531PubMedGoogle Scholar
  142. Homesley HD, Bundy BN, Sedlis A, Adcock L (1986) Radiation therapy versus pelvic node resection for carcinoma of the vulva with positive groin nodes. Obstet Gynecol 68(6):733–740 Epub 1986/12/01PubMedGoogle Scholar
  143. Homesley HDBB, Sedlis A, Yordan E, Berek JS, Jahshan A, Mortel R (1991) Assessment of current International Federation of Gynecology and Obstetrics staging of vulvar carcinoma relative to prognostic factors for survival (a Gynecologic Oncology Group study). Am J Obstet Gynecol 164(4):997–1004PubMedGoogle Scholar
  144. Homesley HD, Bundy BN, Sedlis A, Yordan E, Berek JS, Jahshan A et al (1993) Prognostic factors for groin node metastasis in squamous cell carcinoma of the vulva (a Gynecologic Oncology Group study). Gynecol Oncol 49(3):279–283PubMedGoogle Scholar
  145. Hopkins MP, Morley GW (1991) Radical hysterectomy versus radiation therapy for stage IB squamous cell cancer of the cervix. Cancer 68(2):272–277 Epub 1991/07/15PubMedGoogle Scholar
  146. Howlader N, Noone AM, Krapcho M, Garshell J, Neyman N, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds) (2013) SEER Cancer Statistics Review, 1975–2010. National Cancer Institute, Bethesda. Accessed 13 April 2013, based on November 2 SEER data submission, posted to the SEER web site
  147. Hricak H (1991) Cancer of the uterus: the value of MRI pre-and post-irradiation. Int J Rad Oncol Biol Phys 21:1089–1094Google Scholar
  148. Hricak H, Lacey CG, Sandles LG, Chang YC, Winkler ML, Stern JL (1988) Invasive cervical carcinoma: comparison of MR imaging and surgical findings. Radiology 166:623–631PubMedGoogle Scholar
  149. Hricak H, Gatsonis C, Chi DS, Amendola MA, Brandt K, Schwartz LH, Koelliker S, Siegelman ES, Brown JJ, McGhee RB Jr, Iyer R, Vitellas KM, Snyder B, Long HJ 3rd, Fiorica JV, Mitchell DG (2005) American College of Radiology Imaging Network 6651, Gynecologic Oncology Group 183,. Role of imaging in pretreatment evaluation of early invasive cervical cancer: results of the intergroup study American College of Radiology Imaging Network 6651-Gynecologic Oncology Group 183. J Clin Oncol 23(36):9329–9337Google Scholar
  150. Hsu CT, Cheng YS, Su SC (1972) Prognosis of uterine cervical cancer with extensive lymph node metastases. Special emphasis on the value of pelvic lymphadenectomy in the surgical treatment of uterine cervical cancer. Am J Obstet Gynecol 114(7):954–962. Epub 1972/12/01Google Scholar
  151. Huang YT, Wang CC, Tsai CS, Lai CH, Chang TC, Chou HH et al (2011) Long-term outcome and prognostic factors for adenocarcinoma/adenosquamous carcinoma of cervix after definitive radiotherapy. Int J Radiat Oncol Biol Phys 80(2):429–436 Epub 2010/06/15PubMedGoogle Scholar
  152. Huang YT, Wang CC, Tsai CS, Lai CH, Chang TC, Chou HH et al (2012) Clinical behaviors and outcomes for adenocarcinoma or adenosquamous carcinoma of cervix treated by radical hysterectomy and adjuvant radiotherapy or chemoradiotherapy. Int J Radiat Oncol Biol Phys 84(2):420–427 Epub 2012/03/01PubMedGoogle Scholar
  153. Hunter DJ (1975) Carcinoma of the vulva: a review of 361 patients. Gynecol Oncol 3(2):117–123PubMedGoogle Scholar
  154. Husseinzadeh N, Wesseler T, Schneider D, Schellhas H, Nahhas W (1990) Prognostic factors and the significance of cytologic grading in invasive squamous cell carcinoma of the vulva: a clinicopathologic study. Gynecol Oncol 36(2):192–199PubMedGoogle Scholar
  155. Irwin C, Levin W, Fyles A, Pintilie M, Manchul L, Kirkbride P (1998) The role of adjuvant radiotherapy in carcinoma of the endometrium-results in 550 patients with pathologic stage I disease. Gynecol Oncol 70(2):247–254 Epub 1998/09/19PubMedGoogle Scholar
  156. Ito K, Matsumoto T, Nakada T, Nakanishi T, Fujita N, Yamashita H (1994) Assessing myometrial invasion by endometrial carcinoma with dynamic MRI. J Comput Assist Tomogr 18(1):77–86PubMedGoogle Scholar
  157. Iversen T, Aalders J, Christensen A, Kolstad P (1980) Squamous cell carcinoma of the vulva: a review of 424 patients, 1956-1974. Gynecol Oncol 9(3):271–279PubMedGoogle Scholar
  158. Jach R, Dyduch G, Radon-Pokracka M, Przybylska P, Mika M, Dulinska-Litewka J et al (2011) Expression of vascular endothelial growth factors VEGF- C and D, VEGFR-3, and comparison of lymphatic vessels density labeled with D2-40 antibodies as a prognostic factors in vulvar intraepithelial neoplasia (VIN) and invasive vulvar cancer. Neuro Endocrinol Lett 32(4):530–539PubMedGoogle Scholar
  159. Jantarasaengaram S, Praditphol N, Tansathit T, Vipupinyo C, Vairojanavong K (2013) Three-dimensional ultrasound using volume contrast imaging (VCI) display for the preoperative assessment of myometrial invasion and cervical involvement in endometrial cancer. Ultrasound Obstet Gynecol. Epub 03 Sept 2013Google Scholar
  160. Jeon YT, Park IA, Kim YB, Kim JW, Park NH, Kang SB et al (2006) Steroid receptor expressions in endometrial cancer: clinical significance and epidemiological implication. Cancer Lett 239(2):198–204 Epub 2005/09/20PubMedGoogle Scholar
  161. Johnson GA, Mannel R, Khalifa M, Walker JL, Wren M, Min KW et al (1997) Epidermal growth factor receptor in vulvar malignancies and its relationship to metastasis and patient survival. Gynecol Oncol 65(3):425–429PubMedGoogle Scholar
  162. Kadar N, Malfetano JH, Homesley HD (1993) Steroid receptor concentrations in endometrial carcinoma: effect on survival in surgically staged patients. Gynecol Oncol 50(3):281–286 Epub 1993/09/01PubMedGoogle Scholar
  163. Kagie MJ, Kenter GG, Tollenaar RA, Hermans J, Trimbos JP, Fleuren GJ (1997) p53 protein overexpression, a frequent observation in squamous cell carcinoma of the vulva and in various synchronous vulvar epithelia, has no value as a prognostic parameter. Int J Gynecol Pathol 16(2):124–130PubMedGoogle Scholar
  164. Kainz C, Speiser P, Wanner C (1995) Prognostic value of tumor microvessel density in cancer of the uterine cervix stage IB to IIB. Anticancer Res 15:1549–1551PubMedGoogle Scholar
  165. Kanthan R, Senger JL (2011) Uterine carcinosarcomas (malignant mixed mullerian tumours): a review with special emphasis on the controversies in management. Obstet Gynecol Int 2011:470795PubMedCentralPubMedGoogle Scholar
  166. Kapp KS, Poschauko J, Geyer E, Berghold A, Oechs AC, Petru E et al (2002) Evaluation of the effect of routine packed red blood cell transfusion in anemic cervix cancer patients treated with radical radiotherapy. Int J Radiat Oncol Biol Phys 54(1):58–66 Epub 2002/08/17PubMedGoogle Scholar
  167. Kataoka MY, Sala E, Baldwin P, Reinhold C, Farhadi A, Hudolin T et al (2010) The accuracy of magnetic resonance imaging in staging of vulvar cancer: a retrospective multi-centre study. Gynecol Oncol 117(1):82–87PubMedGoogle Scholar
  168. Keys HM, Bundy BN, Stehman FB, Muderspach LI, Chafe WE, Suggs CL 3rd et al (1999) Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med 340(15):1154–1161 Epub 1999/04/15PubMedGoogle Scholar
  169. Keys HM, Roberts JA, Brunetto VL, Zaino RJ, Spirtos NM, Bloss JD et al (2004) A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study. Gynecol Oncol 92(3):744–751 Epub 2004/02/27PubMedGoogle Scholar
  170. Khalifa MA, Mannel RS, Haraway SD, Walker J, Min KW (1994) Expression of EGFR, HER-2/neu, P53, and PCNA in endometrioid, serous papillary, and clear cell endometrial adenocarcinomas. Gynecol Oncol 53(1):84–92 Epub 1994/04/01PubMedGoogle Scholar
  171. Kidd EASB, Dehdashti F, Grigsby PW (2007) The standardized uptake value for F-18 fluorodeoxyglucose is a sensitive predictive biomarker for cervical cancer treatment response and survival. Cancer 110(8):1738–1744PubMedGoogle Scholar
  172. Kim SH, Kim HD, Song YS, Kang SB, Lee HP (1995) Detection of deep myometrial invasion in endometrial carcinoma: comparison of transvaginal ultrasound, CT, and MRI. J Comput Assist Tomogr 19(5):766–772 Epub 1995/09/01PubMedGoogle Scholar
  173. Kinkel K, Kaji Y, Yu KK, Segal MR, Lu Y, Powell CB et al (1999) Radiologic staging in patients with endometrial cancer: a meta-analysis. Radiology 212(3):711–718PubMedGoogle Scholar
  174. Kirkbride P, Fyles A, Rawlings GA, Manchul L, Levin W, Murphy KJ, Simm J (1995) Carcinoma of the vagina—experience at the Princess Margaret Hospital (1974–1989). Gynecol Oncol 56(3):435–443 Epub 1995/03/01PubMedGoogle Scholar
  175. Kitahara O, Katagiri T, Tsunoda T (2002) Classification of sensitivity or resistance of cervical cancers to ionizing radiation according to expression profiles of 62 genes selected by cDNA microarrayanalysis. Neoplasia 4:295–303PubMedCentralPubMedGoogle Scholar
  176. Kitajima K, Murakami K, Yamasaki E, Hagiwara S, Fukasawa I, Inaba N et al (2008) Performance of FDG-PET/CT in the diagnosis of recurrent endometrial cancer. Ann Nucl Med 22(2):103–109PubMedGoogle Scholar
  177. Kitajima K, Kita M, Suzuki K, Senda M, Nakamoto Y, Sugimura K (2012) Prognostic significance of SUVmax (maximum standardized uptake value) measured by [(1)(8)F]FDG PET/CT in endometrial cancer. Eur J Nucl Med Mol Imaging 39(5):840–845PubMedGoogle Scholar
  178. Kleine W, Rau K, Schwoeorer D, Pfleiderer A (1989) Prognosis of the adenocarcinoma of the cervix uteri: a comparative study. Gynecol Oncol 35(2):145–149 Epub 1989/11/01PubMedGoogle Scholar
  179. Klopp AH, Jingran A, Ramdas L (2008) Gene expression changes in cervical squamous cell carcinoma after initiation of chemoradiation and correlation with clnical outcome. Int J Radiat Oncol Biol Phys 71:226–236PubMedGoogle Scholar
  180. Knopp S, Bjorge T, Nesland JM, Trope C, Scheistroen M, Holm R (2004) p16INK4a and p21Waf1/Cip1 expression correlates with clinical outcome in vulvar carcinomas. Gynecol Oncol 95(1):37–45PubMedGoogle Scholar
  181. Kock L, Mahner S, Choschzick M, Eulenburg C, Milde-Langosch K, Schwarz J et al (2011) Serum carbonic anhydrase IX and its prognostic relevance in vulvar cancer. Int J Gynecol Cancer 21(1):141–148PubMedGoogle Scholar
  182. Kohlberger P, Kainz C, Breitenecker G, Gitsch G, Sliutz G, Kolbl H et al (1995) Prognostic value of immunohistochemically detected p53 expression in vulvar carcinoma. Cancer 76(10):1786–1789PubMedGoogle Scholar
  183. Kolstad P (1968) Intercapillary distance, oxygen tension and local recurrence in cervix cancer. Scand J Clin Lab Invest 106(Suppl):145–157Google Scholar
  184. Komaki R, Mattingly R, Hoffman RG, Barber SW, Satre R, Greenberg M (1983) Irradiation of para-aortic lymph node metastases from carcinoma of the cervix or endometrium. Preliminary results. Radiology 147(1):245–248PubMedGoogle Scholar
  185. Konecny GE, Santos L, Winterhoff B, Hatmal M, Keeney GL, Mariani A et al (2009) HER2 gene amplification and EGFR expression in a large cohort of surgically staged patients with nonendometrioid (type II) endometrial cancer. Br J Cancer 100(1):89–95 Epub 2008/12/18PubMedCentralPubMedGoogle Scholar
  186. Kong A, Simera I, Collingwood M, Williams C, Kitchener H, Cochrane Gynaecological Cancer Group (2007) Adjuvant radiotherapy for stage I endometrial cancer: systematic review and meta-analysis. Ann Oncol 18(10):1595–1604Google Scholar
  187. Kosary CL (1994) FIGO stage, histology, histologic grade, age and race as prognostic factors in determining survival for cancers of the female gynecological system: an analysis of 1973-87 SEER cases of cancers of the endometrium, cervix, ovary, vulva, and vagina. Semin Surg Oncol 10(1):31–46 Epub 1994/01/01PubMedGoogle Scholar
  188. Kovalic JJ, Perez CA, Grigsby PW et al (1991) The effect of volume of disease in patients with carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 21:905–910Google Scholar
  189. Kowalewska M, Radziszewski J, Goryca K, Bujko M, Oczko-Wojciechowska M, Jarzab M et al (2012) Estimation of groin recurrence risk in patients with squamous cell vulvar carcinoma by the assessment of marker gene expression in the lymph nodes. BMC Cancer 12:223PubMedCentralPubMedGoogle Scholar
  190. Krupp PJ, Bohm JW (1978) Lymph gland metastases in invasive squamous cell cancer of the vulva. Am J Obstet Gynecol 130(8):943–952PubMedGoogle Scholar
  191. Kruse AJ, Bottenberg MJ, Tosserams J, Slangen B, van Marion AM, van Trappen PO (2008) The absence of high-risk HPV combined with specific p53 and p16INK4a expression patterns points to the HPV-independent pathway as the causative agent for vulvar squamous cell carcinoma and its precursor simplex VIN in a young patient. Int J Gynecol Pathol 27(4):591–595PubMedGoogle Scholar
  192. Kucera H, Vavra N (1991) Radiation management of primary carcinoma of the vagina: clinical and histopathological variables associated with survival. Gynecol Oncol 40(1):12–16PubMedGoogle Scholar
  193. Kudela M, Pilka R, Lubusky M, Hejtmanek P, Dzubak P, Brychtova S (2012) Prognostic importance of selected molecular immunohistochemical markers and DNA ploidy in endometrial cancer. Eur J Gynaecol Oncol 33(2):159–163 Epub 2012/05/23PubMedGoogle Scholar
  194. Kutlubay Z, Engin B, Zara T, Tuzun Y (2013) Anogenital malignancies and premalignancies: facts and controversies. Clin Dermatol 31(4):362–373PubMedGoogle Scholar
  195. Lambrou NC, Gomez-Marin O, Mirhashemi R, Beach H, Salom E, Almeida-Parra Z et al (2004) Optimal surgical cytoreduction in patients with Stage III and Stage IV endometrial carcinoma: a study of morbidity and survival. Gynecol Oncol 93(3):653–658PubMedGoogle Scholar
  196. Lamoreaux WTGP, Dehdashti F, Zoberi I, Powell MA, Gibb RK, Rader JS, Mutch DG, Siegel BA (2005) FDG-PET evaluation of vaginal carcinoma. Int J Radiat Oncol Biol Phys 62(3):733–737PubMedGoogle Scholar
  197. Lanciano R, Calkins A, Bundy BN, Parham G, Lucci JA 3rd, Moore DH et al (2005) Randomized comparison of weekly cisplatin or protracted venous infusion of fluorouracil in combination with pelvic radiation in advanced cervix cancer: a gynecologic oncology group study. J Clin Oncol 23(33):8289–8295PubMedGoogle Scholar
  198. Landoni F, Maneo A, Colombo A, Placa F, Milani R, Perego P et al (1997) Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer. Lancet 350(9077):535–540 Epub 1997/08/23PubMedGoogle Scholar
  199. Larsson GL, Helenius G, Andersson S, Sorbe B, Karlsson MG (2013) Prognostic impact of human papilloma virus (HPV) genotyping and HPV-16 subtyping in vaginal carcinoma. Gynecol Oncol 129(2):406–411PubMedGoogle Scholar
  200. Lataifeh I, Nascimento MC, Nicklin JL, Perrin LC, Crandon AJ, Obermair A (2004) Patterns of recurrence and disease-free survival in advanced squamous cell carcinoma of the vulva. Gynecol Oncol 95(3):701–705PubMedGoogle Scholar
  201. Latta E, Chapman WB (2002) PTEN mutations and evolving concepts in endometrial neoplasia. Curr Opin Obstet Gynecol 14(1):59–65 Epub 2002/01/22PubMedGoogle Scholar
  202. Lavie O, Comerci G, Daras V, Bolger BS, Lopes A, Monaghan JM (1999) Thrombocytosis in women with vulvar carcinoma. Gynecol Oncol 72(1):82–86PubMedGoogle Scholar
  203. Lea JS, Coleman RL, Garner EO, Duska LR, Miller DS, Schorge JO (2003) Adenosquamous histology predicts poor outcome in low-risk stage IB1 cervical adenocarcinoma. Gynecol Oncol 91(3):558–562 Epub 2003/12/17PubMedGoogle Scholar
  204. Lee JH DT, Andreotti RF, Cardenes HR, Dejesus Allison SO, Gaffney DK, Glanc P, Horowitz NS, Jhingran A, Lee SI, Puthawala AA, Royal HD, Scoutt LM, Small W Jr, Varia MA, Zelop CM (2011) Expert panel on women’s imaging and radiation oncology-gynecology. ACR appropriateness Criteria® pretreatment evaluation and follow-up of endometrial cancer of the uterus. Ultrasound Q 27(2):139–145Google Scholar
  205. Lerma E, Matias-Guiu X, Lee SJ, Prat J (1999) Squamous cell carcinoma of the vulva: study of ploidy, HPV, p53, and pRb. Int J Gynecol Pathol 18(3):191–197PubMedGoogle Scholar
  206. Leung SSM (1993) Radical radiation therapy for carcinoma of the vagina—impact of treatment modalities on outcome: Peter MacCallum Cancer Institute experience 1970-1990. Int J Radiat Oncol Biol Phys 25(3):413–418PubMedGoogle Scholar
  207. Levenback CF, Ali S, Coleman RL, Gold MA, Fowler JM, Judson PL et al (2012) Lymphatic mapping and sentinel lymph node biopsy in women with squamous cell carcinoma of the vulva: A Gynecologic Oncology Group Study. J Clin Oncol 30:3786–3791 Epub 04 July 2012Google Scholar
  208. Lewandowski G, Torrisi J, Potkul RK, Holloway RW, Popescu G, Whitfield G et al (1990) Hysterectomy with extended surgical staging and radiotherapy versus hysterectomy alone and radiotherapy in stage I endometrial cancer: a comparison of complication rates. Gynecol Oncol 36(3):401–404PubMedGoogle Scholar
  209. Lewin SN, Herzog TJ, Barrena Medel NI, Deutsch I, Burke WM, Sun X et al (2010) Comparative performance of the 2009 international Federation of gynecology and obstetrics’ staging system for uterine corpus cancer. Obstet Gynecol 116(5):1141–1149. Epub 2010/10/23Google Scholar
  210. Lim K, Chan P, Dinniwell R, Fyles A, Haider M, Cho YB, Jaffray D, Manchul L, Levin W, Hill RP, Milosevic M (2008) Cervical cancer regression measured using weekly magnetic resonance imaging during fractionated radiotherapy: radiobiologic modeling and correlation with tumor hypoxia. Int J Radiat Oncol Biol Phys 70(1):126–133PubMedGoogle Scholar
  211. Lindell G, Nasman A, Jonsson C, Ehrsson RJ, Jacobsson H, Danielsson KG et al (2010) Presence of human papillomavirus (HPV) in vulvar squamous cell carcinoma (VSCC) and sentinel node. Gynecol Oncol 117(2):312–316PubMedGoogle Scholar
  212. Liu S, Semenciw R, Mao Y (2001) Cervical cancer: the increasing incidence of adenocarcinoma and adenosquamous carcinoma in younger women. CMAJ 164(8):1151–1152 Epub 2001/05/08PubMedCentralPubMedGoogle Scholar
  213. Liu Y, Bai R, Sun H, Liu H, Zhao X, Li Y (2009) Diffusion-weighted imaging in predicting and monitoring the response of uterine cervical cancer to combined chemoradiation. Clin Radiol 64:1067–1074Google Scholar
  214. Loncaster JA, Cooper RA, Logue JP, Davidson SE, Hunter RD, West CM (2000) Vascular endothelial growth factor (VEGF) expression is a prognostic factor for radiotherapy outcome in advanced carcinoma of the cervix. Br J Cancer 83:620–625PubMedCentralPubMedGoogle Scholar
  215. Loncaster JA, Carrington BM, Sykes JR, Jones AP, Todd SM, Cooper R et al (2002) Prediction of radiotherapy outcome using dynamic contrast enhanced MRI of carcinoma of the cervix. Int J Rad Oncol Biol Phys 54:759–767Google Scholar
  216. Look KY, Brunetto VL, Clarke-Pearson DL, Averette HE, Major FJ, Alvarez RD et al (1996) An analysis of cell type in patients with surgically staged stage IB carcinoma of the cervix: a Gynecologic Oncology Group study. Gynecol Oncol 63(3):304–311 Epub 1996/12/01PubMedGoogle Scholar
  217. Lowrey GC, Mendenhall MW, Million RR (1992) Stage IB or IIA-B carcinoma of the intact uterine cervix treated with irradiation: a multivariate analysis. Int J Radiat Oncol Biol Phys 24:205–210PubMedGoogle Scholar
  218. Lundgren C, Auer G, Frankendal B, Moberger B, Nilsson B, Nordstrom B (2002) Nuclear DNA content, proliferative activity, and p53 expression related to clinical and histopathologic features in endometrial carcinoma. Int J Gynecol Cancer 12(1):110–118PubMedGoogle Scholar
  219. Macdonald OK, Chen J, Dodson M, Lee CM, Gaffney DK (2009) Prognostic significance of histology and positive lymph node involvement following radical hysterectomy in carcinoma of the cervix. Am J Clin Oncol 32(4):411–416 Epub 2009/05/20PubMedGoogle Scholar
  220. Mackay HJ, Gallinger S, Tsao MS, McLachlin CM, Tu D, Keiser K et al (2010) Prognostic value of microsatellite instability (MSI) and PTEN expression in women with endometrial cancer: results from studies of the NCIC Clinical Trials Group (NCIC CTG). Eur J Cancer 46(8):1365–1373 Epub 2010/03/23PubMedGoogle Scholar
  221. Madsen BS, Jensen HL, van den Brule AJ, Wohlfahrt J, Frisch M (2008) Risk factors for invasive squamous cell carcinoma of the vulva and vagina—population-based case-control study in Denmark. Int J Cancer 122(12):2827–2834PubMedGoogle Scholar
  222. Manfredi R, Mirk P, Maresca G, Margariti PA, Testa A, Zannoni GF et al (2004) Local-regional staging of endometrial carcinoma: role of MR imaging in surgical planning. Radiology 231(2):372–378PubMedGoogle Scholar
  223. Mariani L, Conti L, Atlante G, Sciarretta F, Pozzi M, Vercillo M, Francavilla V, De Franceschi L, Rossi S, Sindico R, Atlante M, Gandolfo GM (1998) Vulvar squamous carcinoma: prognostic role of DNA content. Gynecol Oncol 71(2):159–164PubMedGoogle Scholar
  224. Mariani A, Sebo TJ, Katzmann JA, Keeney GL, Roche PC, Lesnick TG et al (2000) Pretreatment assessment of prognostic indicators in endometrial cancer. Am J Obstet Gynecol 182(6):1535–1544 Epub 2000/06/28PubMedGoogle Scholar
  225. Mariani A, Webb MJ, Keeney GL, Haddock MG, Aletti G, Podratz KC (2002a) Stage IIIC endometrioid corpus cancer includes distinct subgroups. Gynecol Oncol 87(1):112–117 Epub 2002/12/07PubMedGoogle Scholar
  226. Mariani A, Webb MJ, Keeney GL, Aletti G, Podratz KC (2002b) Predictors of lymphatic failure in endometrial cancer. Gynecol Oncol 84(3):437–442PubMedGoogle Scholar
  227. Mariani A, Webb MJ, Keeney GL, Aletti G, Podratz KC (2002c) Assessment of prognostic factors in stage IIIA endometrial cancer. Gynecol Oncol 86(1):38–44PubMedGoogle Scholar
  228. Martin-Hirsch PP, Bryant A, Keep SL, Kitchener HC, Lilford R (2011) Adjuvant progestagens for endometrial cancer. Cochrane Database Syst Rev 6:CD001040. Epub 2011/06/17Google Scholar
  229. Maxwell GL, Risinger JI, Alvarez AA, Barrett JC, Berchuck A (2001) Favorable survival associated with microsatellite instability in endometrioid endometrial cancers. Obstet Gynecol 97(3):417–422 Epub 2001/03/10PubMedGoogle Scholar
  230. Mayr A, Wang JZ, D Z, Montebello JF, Grecula JC, Lo SS et al (2009) Synergistic effects of hemoglobin and tumor perfusion on tumor control and survival in cervical cancer. Int J Radiat Oncol Biol Phys 74(5):1513–1521Google Scholar
  231. Mayr NA, Magnotta VA, Ehrhardt JC, Wheeler JA, Sorosky JI, Wen BC et al (1996) Usefulness of tumor volumetry by magnetic resonance imaging in assessing response to radiation therapy in carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 35(5):915–924PubMedGoogle Scholar
  232. Mayr NA, Hawighorst H, Yuh WTC, Essig M, Magnotta VA, Knopp MV (1999) MR microcirculation in cervical cancer: correlations with histomorphological tumor markers and clinical outcome. J Magn Reson Imaging 10:267–276PubMedGoogle Scholar
  233. Mayr NA, Yuh WTC, Taoka T, Wang JZ, Wu DH, Montebello JF et al (2006) Serial therapy-induced changes in tumor shape in cervical cancer and their impact on assessing tumor volume and treatment response. Am J Roentgenol 187:65–72Google Scholar
  234. Mayr NA, Wang JZ, Lo SS, Zhang D, Grecula JC, Lu L et al (2010) Translating response during therapy into ultimate treatment outcome: a personalized 4-dimensional MRI tumor volumetric regression approach in cervical cancer. Int J Radiat Oncol Biol Phys 76:719–727 (23 July 2009, Epub ahead of print) Google Scholar
  235. McConnell DT, Miller ID, Parkin DE, Murray GI (1997) p53 protein expression in a population-based series of primary vulval squamous cell carcinoma and immediate adjacent field change. Gynecol Oncol 67(3):248–254PubMedGoogle Scholar
  236. Mell LK, Meyer JJ, Tretiakova M, Khramtsov A, Gong C, Yamada SD et al (2004) Prognostic significance of E-cadherin protein expression in pathological stage I-III endometrial cancer. Clin Cancer Res 10(16):5546–5553 Epub 2004/08/26PubMedGoogle Scholar
  237. Mendenhall WM, Thar TL, Bova FJ, Marcus RB Jr, Morgan LS, Million RR (1984) Prognostic and treatment factors affecting pelvic control of stage IB and IIA-B carcinoma of the intact uterine cervix treated with radiation therapy alone. Cancer 53:2649–2654PubMedGoogle Scholar
  238. Milgrom SA, Kollmeier MA, Abu-Rustum NR, Makker V, Gardner GJ, Barakat RR et al (2013) Positive peritoneal cytology is highly predictive of prognosis and relapse patterns in stage III (FIGO 2009) endometrial cancer. Gynecol Oncol 130(1):49–53PubMedGoogle Scholar
  239. Monk BJBR, Lin F, Parham G, Vasilev SA, Wilczynski SP (1995) Prognostic significance of human papillomavirus DNA in vulvar carcinoma. Obstet Gynecol 85:709–715PubMedGoogle Scholar
  240. Montana GS, Thomas GM, Moore DH, Saxer A, Mangan CE, Lentz SS et al (2000) Preoperative chemo-radiation for carcinoma of the vulva with N2/N3 nodes: a gynecologic oncology group study. Int J Radiat Oncol Biol Phys 48(4):1007–1013PubMedGoogle Scholar
  241. Moore DH, Ali S, Koh WJ, Michael H, Barnes MN, McCourt CK et al (2012) A phase II trial of radiation therapy and weekly cisplatin chemotherapy for the treatment of locally-advanced squamous cell carcinoma of the vulva: a gynecologic oncology group study. Gynecol Oncol 124(3):529–533PubMedGoogle Scholar
  242. Morice P, Castaigne D, Pautier P, Rey A, Haie-Meder C, Leblanc M et al (1999) Interest of pelvic and paraaortic lymphadenectomy in patients with stage IB and II cervical carcinoma. Gynecol Oncol 73(1):106–110 Epub 1999/03/30PubMedGoogle Scholar
  243. Morley GW, Seski JC (1976) Radical pelvic surgery versus radiation therapy for stage I carcinoma of the cervix (exclusive of microinvasion). Am J Obstet Gynecol 126(7):785–798 Epub 1976/12/01PubMedGoogle Scholar
  244. Morris M, Eifel PJ, Lu J, Grigsby PW, Levenback C, Stevens RE et al (1999) Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med 340:1137–1143PubMedGoogle Scholar
  245. Morrow (1980) Is pelvic radiation beneficial in the postoperative management of stage Ib squamous cell carcinoma of the cervix with pelvic node metastasis treated by radical hysterectomy and pelvic lymphadenectomy? A report from the Presidential Panel at the 1979 Annual Meeting of the Society of Gynecologic Oncologists (1980) Gynecol Oncol 10(1):105–110Google Scholar
  246. Morrow CP, Bundy BN, Kurman RJ, Creasman WT, Heller P, Homesley HD et al (1991) Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study. Gynecol Oncol 40(1):55–65PubMedGoogle Scholar
  247. Naganawa S, Sato C, Kumada H, Ishigaki T, Miura S, Takizawa O (2005). Apparent diffusion coefficient in cervical cancer of the uterus: comparison with the normal uterine cervix. Eur Radiol 15:71–78Google Scholar
  248. Nagar H, Dobbs S, McClelland HR, Price J, McCluggage WG, Grey A (2006) The diagnostic accuracy of magnetic resonance imaging in detecting cervical involvement in endometrial cancer. Gynecol Oncol 103(2):431–434PubMedGoogle Scholar
  249. Nakamura K, Kodama J, Okumura Y, Hongo A, Kanazawa S, Hiramatsu Y (2010) The SUVmax of 18F-FDG PET correlates with histological grade in endometrial cancer. Int J Gynecol Cancer 20(1):110–115PubMedGoogle Scholar
  250. Nakamura K, Hongo A, Kodama J, Hiramatsu Y (2011) The measurement of SUVmax of the primary tumor is predictive of prognosis for patients with endometrial cancer. Gynecol Oncol 123(1):82–87PubMedGoogle Scholar
  251. Nakamura K, Joja I, Fukushima C, Haruma T, Hayashi C, Kusumoto T et al (2013) The preoperative SUVmax is superior to ADCmin of the primary tumour as a predictor of disease recurrence and survival in patients with endometrial cancer. Eur J Nucl Med Mol Imaging 40(1):52–60PubMedGoogle Scholar
  252. Nicoletto MO, Parenti A, Del Bianco P, Lombardi G, Pedrini L, Pizzi S, Carli P, Della Palma M, Pastorelli D, Corti L, Becagli L (2010) Vulvar cancer: prognostic factors. Anticancer Res 30(6):2311–2317Google Scholar
  253. Nordstrom B, Strang P, Lindgren A, Bergstrom R, Tribukait B (1996) Carcinoma of the endometrium: do the nuclear grade and DNA ploidy provide more prognostic information than do the FIGO and WHO classifications? Int J Gynecol Pathol 15(3):191–201PubMedGoogle Scholar
  254. Nori D, Hilaris B, Stanimir G, Lewis JL Jr (1983) Radiation therapy of primary vaginal carcinoma. Int J Radiat Oncol Biol Phys 9(10):1471–1475PubMedGoogle Scholar
  255. Nout RA, Smit VT, Putter H, Jurgenliemk-Schulz IM, Jobsen JJ, Lutgens LC et al (2010) Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial. Lancet 375(9717):816–823 Epub 2010/03/09PubMedGoogle Scholar
  256. Nout RA, Bosse T, Creutzberg CL, Jurgenliemk-Schulz IM, Jobsen JJ, Lutgens LC et al (2012) Improved risk assessment of endometrial cancer by combined analysis of MSI, PI3 K-AKT, Wnt/beta-catenin and P53 pathway activation. Gynecol Oncol 126(3):466–473PubMedGoogle Scholar
  257. Obermair A, Kohlberger P, Bancher-Todesca D, Tempfer C, Sliutz G, Leodolter S et al (1996) Influence of microvessel density and vascular permeability factor/vascular endothelial growth factor expression on prognosis in vulvar cancer. Gynecol Oncol 63(2):204–209PubMedGoogle Scholar
  258. Obermair A, Wanner C, Bilgi S, Speiser P, Kaider A, Rheinthaller A et al (1998) Tumor angiogenesis in stage IB cervical cancer: correlaion of microvessel density with survival. Am J Obstet Gynecol 178:314–319PubMedGoogle Scholar
  259. Okagaki T, Twiggs LB, Zachow KR, Clark BA, Ostrow RS, Faras AJ (1983) Identification of human papillomavirus DNA in cervical and vaginal intraepithelial neoplasia with molecularly cloned virus-specific DNA probes. Int J Gynecol Pathol 2(2):153–159PubMedGoogle Scholar
  260. Oonk MH, van Hemel BM, Hollema H, de Hullu JA, Ansink AC, Vergote I et al (2010) Size of sentinel-node metastasis and chances of non-sentinel-node involvement and survival in early stage vulvar cancer: results from GROINSS-V, a multicentre observational study. Lancet Oncol 11(7):646–652PubMedGoogle Scholar
  261. Orezzoli JP, Sioletic S, Olawaiye A, Oliva E, del Carmen MG (2009) Stage II endometrioid adenocarcinoma of the endometrium: clinical implications of cervical stromal invasion. Gynecol Oncol 113(3):316–323PubMedGoogle Scholar
  262. Origoni M, Sideri M, Garsia S, Carinelli SG, Ferrari AG (1992) Prognostic value of pathological patterns of lymph node positivity in squamous cell carcinoma of the vulva stage III and IVA FIGO. Gynecol Oncol 45(3):313–316PubMedGoogle Scholar
  263. Ota T, Yoshida M, Kimura M, Kinoshita K (2005) Clinicopathologic study of uterine endometrial carcinoma in young women aged 40 years and younger. Int J Gynecol Cancer 15(4):657–662 Epub 2005/07/15PubMedGoogle Scholar
  264. Paladini D, Cross P, Lopes A, Monaghan JM (1994) Prognostic significance of lymph node variables in squamous cell carcinoma of the vulva. Cancer 74(9):2491–2496PubMedGoogle Scholar
  265. Park JY, Kim EN, Kim DY, Kim JH, Kim YM, Kim YT et al (2008) Clinical impact of positron emission tomography or positron emission tomography/computed tomography in the posttherapy surveillance of endometrial carcinoma: evaluation of 88 patients. Int J Gynecol Cancer 18(6):1332–1338PubMedGoogle Scholar
  266. Pecorelli S (2009) Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet 105(2):103–104PubMedGoogle Scholar
  267. Pecorelli S, Zigliani L, Odicino F (2009) Revised FIGO staging for carcinoma of the cervix. Int J Gynaecol Obstet 105(2):107–108PubMedGoogle Scholar
  268. Perez CA, Camel HM, Galakatos AE, Grigsby PW, Kuske RR, Buchsbaum G et al (1988) Definitive irradiation in carcinoma of the vagina: long-term evaluation of results. Int J Radiat Oncol Biol Phys 15(6):1283–1290PubMedGoogle Scholar
  269. Perez CA, Grigsby P, Nene S et al (1992a) Effect of tumor size on the prognosis of carcinoma of the uterine cervix treated with irradiation alone. Cancer 69:2796–2806Google Scholar
  270. Perez C, Grigsby P, Nene S et al (1992b) Effect of tumor size on the prognosis of carcinoma of the uterine cervix treated with irradiation alone. Cancer 69:2796–2806PubMedGoogle Scholar
  271. Perez CAGP, Garipagaoglu M, Mutch DG, Lockett MA (1999) Factors affecting long-term outcome of irradiation in carcinoma of the vagina. Int J Radiat Oncol Biol Phys 44(1):37–45PubMedGoogle Scholar
  272. Pilch H, Gunzel S, Schaffer U, Tanner B, Brockerhoff P, Maeurer M et al (2001) The presence of HPV DNA in cervical cancer: correlation with clinico-pathologic parameters and prognostic significance: 10 years experience at the Department of Obstetrics and Gynecology of the Mainz University. Int J Gynecol Cancer 11(1):39–48 Epub 2001/04/04PubMedGoogle Scholar
  273. Pingley S, Shrivastava SK, Sarin R, Agarwal JP, Laskar S, Deshpande DD et al (2000) Primary carcinoma of the vagina: Tata Memorial Hospital experience. Int J Radiat Oncol Biol Phys 46(1):101–108 Epub 2000/02/03PubMedGoogle Scholar
  274. Podratz KCSR, Taylor WF, Williams TJ (1983) Carcinoma of the vulva: analysis of treatment and survival. Obstet Gynecol 61(1):63–74PubMedGoogle Scholar
  275. Powell JL, Hill KA, Shiro BC, Diehl SJ, Gajewski WH (2005) Preoperative serum CA-125 levels in treating endometrial cancer. J Reprod Med 50(8):585–590 Epub 2005/10/14PubMedGoogle Scholar
  276. Prat J (2009) FIGO staging for uterine sarcomas. Int J Gynaecol Obstet 104(3):177–178PubMedGoogle Scholar
  277. Prat J, Oliva E, Lerma E, Vaquero M, Matias-Guiu X (1994) Uterine papillary serous adenocarcinoma. A 10-case study of p53 and c-erbB-2 expression and DNA content. Cancer 74(6):1778–1783PubMedGoogle Scholar
  278. Prempree T, Amornmarn R (1985) Radiation treatment of primary carcinoma of the vagina. Patterns of failures after definitive therapy. Acta Radiologica Oncol 24(1):51–56. Epub 1985/01/01Google Scholar
  279. Prompeler HJ, Madjar H, du Bois A, Lattermann U, Wilhelm C, Kommoss F et al (1994) Transvaginal sonography of myometrial invasion depth in endometrial cancer. Acta Obstet Gynecol Scand 73(4):343–346 Epub 1994/04/01PubMedGoogle Scholar
  280. Peters WA r, Liu PY, Barrett RJ 2nd et al (2000) Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol18:1606–1613Google Scholar
  281. Ragnarsson-Olding B, Johansson H, Rutqvist LE, Ringborg U (1993) Malignant melanoma of the vulva and vagina. Trends in incidence, age distribution, and long-term survival among 245 consecutive cases in Sweden 1960-1984. Cancer 71(5):1893–1897PubMedGoogle Scholar
  282. Ramanah R, Lesieur B, Ballester M, Darai E, Rouzier R (2012) Trends in of late-stage squamous cell vulvar carcinomas: analysis of the surveillance, epidemiology, and end results (SEER) database. Int J Gynecol Cancer 22(5):854–859PubMedGoogle Scholar
  283. Randall ME, Filiaci VL, Muss H, Spirtos NM, Mannel RS, Fowler J et al (2006) Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group Study. J Clin Oncol 24(1):36–44PubMedGoogle Scholar
  284. Randall LM, Monk BJ, Darcy KM, Tian C, Burger RA, Liao SY et al (2009) Markers of angiogenesis in high-risk, early-stage cervical cancer: a Gynecologic Oncology Group study. Gynecol Oncol 112(3):583–589 Epub 2008/12/27PubMedCentralPubMedGoogle Scholar
  285. Raspagliesi F, Hanozet F, Ditto A, Solima E, Zanaboni F, Vecchione F, Kusamura S (2006) Clinical and pathological prognostic factors in squamous cell carcinoma of the vulva. Gynecol Oncol 102(2):333–337Google Scholar
  286. Rauh-Hain JA, Del Carmen MG (2013) Endometrial stromal sarcoma: a systematic review. Obstet Gynecol 122(3):676–683PubMedGoogle Scholar
  287. Rose PG, Bundy BN, Watkins EB, Thigpen JT, Deppe G, Maiman MA et al (1999) Concurrent Cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 340:1144–1153PubMedGoogle Scholar
  288. Rose PGAS, Watkins E, Thigpen JT, Deppe G, Clarke-Pearson DL, Insalaco S (2007) Long-term follow-up of a randomized trial comparing concurrent single agent cisplatin, cisplatin-based combination chemotherapy, or hydroxyurea during pelvic irradiation for locally advanced cervical cancer: a Gynecologic Oncology Group Study. J Clin Oncol 25:2804–2810PubMedGoogle Scholar
  289. Ross JC, Eifel PJ, Cox RS, Kempson RL, Hendrickson MR (1983) Primary mucinous adenocarcinoma of the endometrium. A clinicopathologic and histochemical study. Am J Surg Pathol 7(8):715–729PubMedGoogle Scholar
  290. Ross BDMB, Lawrence TS, Mukherji SK, Gebarski SS, Quint DJ, Johnson TD, Junck L, Robertson PL, Muraszko KM, Dong Q, Meyer CR, Bland PH, McConville P, Geng H, Rehemtulla A, Chenevert TL (2003) Evaluation of cancer therapy using diffusion magnetic resonance imaging. Mol Cancer Ther 2(6):581–587PubMedGoogle Scholar
  291. Rotman M, Aziz H, Eifel PJ (1994) Irradiation of pelvic and para-aortic nodes in carcinoma of the cervix. Semin Radiat Oncol 4(1):23–29PubMedGoogle Scholar
  292. Rotman M, Sedlis A, Piedmonte MR, Bundy B, Lentz SS, Muderspach LI, Zaino RJ (2006) A phase III randomized trial of postoperative pelvic irradiation in Stage IB cervical carcinoma with poor prognostic features: follow-up of a gynecologic oncology group study. Int J Radiat Oncol Biol Phys 65(1):169–176PubMedGoogle Scholar
  293. Rouzier R, Haddad B, Plantier F, Dubois P, Pelisse M, Paniel BJ (2002) Local relapse in patients treated for squamous cell vulvar carcinoma: incidence and prognostic value. Obstet Gynecol 100(6):1159–1167Google Scholar
  294. Rutledge F, Smith J, Franklin EW (1970) Carcinoma of the vulva. Am J Obstet Gynecol 106(8):1117–1130PubMedGoogle Scholar
  295. Saez F, Urresola A, Larena JA, Martin JI, Pijuan JI, Schneider J et al (2000) Endometrial carcinoma: assessment of myometrial invasion with plain and gadolinium-enhanced MR imaging. J Magn Reson Imaging 12(3):460–466PubMedGoogle Scholar
  296. Saffari B, Bernstein L, Hong DC, Sullivan-Halley J, Runnebaum IB, Grill HJ et al (2005) Association of p53 mutations and a codon 72 single nucleotide polymorphism with lower overall survival and responsiveness to adjuvant radiotherapy in endometrioid endometrial carcinomas. Int J Gynecol Cancer 15(5):952–963 Epub 2005/09/22PubMedGoogle Scholar
  297. Saga T, Higashi T, Ishimori T, Mamede M, Nakamoto Y, Mukai T et al (2003) Clinical value of FDG-PET in the follow up of post-operative patients with endometrial cancer. Ann Nucl Med 17(3):197–203PubMedGoogle Scholar
  298. Sala E, Crawford R, Senior E, Shaw A, Simcock B, Vrotsou K et al (2009) Added value of dynamic contrast-enhanced magnetic resonance imaging in predicting advanced stage disease in patients with endometrial carcinoma. Int J Gynecol Cancer 19(1):141–146PubMedGoogle Scholar
  299. Salani R, Backes FJ, Fung MF, Holschneider CH, Parker LP, Bristow RE et al (2011) Posttreatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncologists recommendations. Am J Obstet Gynecol 204(6):466–478 Epub 2011/07/15PubMedGoogle Scholar
  300. Salvesen HB, Iversen OE, Akslen LA (1998) Identification of high-risk patients by assessment of nuclear Ki-67 expression in a prospective study of endometrial carcinomas. Clin Cancer Res 4(11):2779–2785 Epub 1998/11/26PubMedGoogle Scholar
  301. Santos M, Montagut C, Mellado B, Garcia A, Ramon y Cajal S, Cardesa A et al (2004) Immunohistochemical staining for p16 and p53 in premalignant and malignant epithelial lesions of the vulva. Int J Gynecol Pathol 23(3):206–214Google Scholar
  302. Scheistroen M, Trope C, Pettersen EO, Nesland JM (1999) p53 protein expression in squamous cell carcinoma of the vulva. Cancer 85(5):1133–1138PubMedGoogle Scholar
  303. Schwartz SM, Daling JR, Shera KA, Madeleine MM, McKnight B, Galloway DA et al (2001) Human papillomavirus and prognosis of invasive cervical cancer: a population-based study. J Clin Oncol 19(7):1906–1915 Epub 2001/04/03PubMedGoogle Scholar
  304. Scribner DR Jr, Walker JL, Johnson GA, McMeekin DS, Gold MA, Mannel RS (2002) Laparoscopic pelvic and paraaortic lymph node dissection in the obese. Gynecol Oncol 84(3):426–430PubMedGoogle Scholar
  305. Sedlis A, Bundy B, Rotman MZ, Lentz SS, Muderspach LI, Zaino RJ (1999) A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: A Gynecologic Oncology Group Study. Gynecol Oncol 73(2):177–183PubMedGoogle Scholar
  306. Selman TJ, Luesley DM, Acheson N, Khan KS, Mann CH (2005) A systematic review of the accuracy of diagnostic tests for inguinal lymph node status in vulvar cancer. Gynecol Oncol 99(1):206–214PubMedGoogle Scholar
  307. Sethi TK, Bhalla NK, Jena AN, Rawat S, Oberoi R (2005) Magnetic resonance imaging in carcinoma cervix—does it have a prognostic relevance. J Cancer Res Ther 1(2):103–107PubMedGoogle Scholar
  308. Shah CA, Goff BA, Lowe K, Peters WA 3rd, Li CI (2009) Factors affecting risk of mortality in women with vaginal cancer. Obstet Gynecol 113(5):1038–1045PubMedCentralPubMedGoogle Scholar
  309. Shingleton HM, Bell MC, Fremgen A, Chmiel JS, Russell AH, Jones WB et al (1995) Is there really a difference in survival of women with squamous cell carcinoma, adenocarcinoma, and adenosquamous cell carcinoma of the cervix? Cancer 76(10 Suppl):1948–1955 Epub 1995/11/15PubMedGoogle Scholar
  310. Siegel R, Naishadham D, Jemal A (2012) Cancer statistics, 2012. CA Cancer J Clin 62(1):10–29 Epub 2012/01/13PubMedGoogle Scholar
  311. Siegel R, Naishadham D, Jemal A (2013) Cancer statistics, 2013. CA Cancer J Clin 63(1):11–30PubMedGoogle Scholar
  312. Sillman FH, Fruchter RG, Chen YS, Camilien L, Sedlis A, McTigue E (1997) Vaginal intraepithelial neoplasia: risk factors for persistence, recurrence, and invasion and its management. Am J Obstet Gynecol 176(1 Pt 1):93–99PubMedGoogle Scholar
  313. Silverman MB, Roche PC, Kho RM, Keeney GL, Li H, Podratz KC (2000) Molecular and cytokinetic pretreatment risk assessment in endometrial carcinoma. Gynecol Oncol 77(1):1–7 Epub 2000/03/31PubMedGoogle Scholar
  314. Singh K, Orakwue CO, Honest H, Balogun M, Lopez C, Luesley DM (2006) Accuracy of magnetic resonance imaging of inguinofemoral lymph nodes in vulval cancer. Int J Gynecol Cancer 16(3):1179–1183 Epub 2006/06/29PubMedGoogle Scholar
  315. Singh M, Darcy KM, Brady WE, Clubwala R, Weber Z, Rittenbach JV et al (2011) Cadherins, catenins and cell cycle regulators: impact on survival in a Gynecologic Oncology Group phase II endometrial cancer trial. Gynecol Oncol 123(2):320–328 Epub 2011/08/05PubMedCentralPubMedGoogle Scholar
  316. Sironi S, Colombo E, Villa G, Taccagni G, Belloni C, Garancini P et al (1992) Myometrial invasion by endometrial carcinoma: assessment with plain and gadolinium-enhanced MR imaging. Radiology 185(1):207–212PubMedGoogle Scholar
  317. Smith HO, Tiffany MF, Qualls CR, Key CR (2000) The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States—a 24-year population-based study. Gynecol Oncol 78(2):97–105 Epub 2000/08/06PubMedGoogle Scholar
  318. Sohaib SA, Richards PS, Ind T, Jeyarajah AR, Shepherd JH, Jacobs IJ et al (2002) MR imaging of carcinoma of the vulva. Am J Roentgenol 178(2):373–377Google Scholar
  319. Stang A, Streller B, Eisinger B, Jockel KH (2005) Population-based incidence rates of malignant melanoma of the vulva in Germany. Gynecol Oncol 96(1):216–221PubMedGoogle Scholar
  320. Stehman FBBB, DiSaia PJ, Keys HM, Larson JE, Fowler WC (1991) Carcinoma of the cervix treated with radiation therapy. I. A multi-variate analysis of prognostic variables in the Gynecologic Oncology Group. Cancer 67(11):2776–2785PubMedGoogle Scholar
  321. Steinbakk A, Malpica A, Slewa A, Skaland I, Gudlaugsson E, Janssen EA et al (2011) Biomarkers and microsatellite instability analysis of curettings can predict the behavior of FIGO stage I endometrial endometrioid adenocarcinoma. Mod Pathol 24(9):1262–1271 Epub 2011/05/10PubMedGoogle Scholar
  322. Stone JE, Parker R, Gilks CB, Stanbridge EJ, Liao SY, Aquino-Parsons C (2005) Intratumoral oxygenation of invasive squamous cell carcimoma of the vulva is not correlated with regional lymph node metastasis. Eur J Gynaecol Oncol 26(1):31–35PubMedGoogle Scholar
  323. Sugiyama VE, Chan JK, Shin JY, Berek JS, Osann K, Kapp DS (2007) Vulvar melanoma: a multivariable analysis of 644 patients. Obstet Gynecol 110(2 Pt 1):296–301PubMedGoogle Scholar
  324. Szantho A, Szabo I, Csapo ZS, Balega J, Demeter A, Papp Z (2001) Assessment of myometrial and cervical invasion of endometrial cancer by transvaginal sonography. Eur J Gynaecol Oncol 22(3):209–212 Epub 2001/08/15PubMedGoogle Scholar
  325. Sznurkowski JJ, Milczek T, Emerich J (2013) Prognostic factors and a value of 2009 FIGO staging system in vulvar cancer. Arch Gynecol Obstet 287(6):1211–1218PubMedCentralPubMedGoogle Scholar
  326. Tabbaa ZM, Gonzalez J, Sznurkowski JJ, Weaver AL, Mariani A, Cliby WA (2012) Impact of the new FIGO 2009 staging classification for vulvar cancer on prognosis and stage distribution. Gynecol Oncol 127(1):147–152PubMedGoogle Scholar
  327. Takahashi K, Yoshioka M, Kosuge H, Iizuka Y, Musha T, Yamauchi I et al (1995) The accuracy of computed tomography and magnetic resonance imaging in evaluating the extent of endometrial carcinoma. Nihon Sanka Fujinka Gakkai Zasshi. 47(7):647–654PubMedGoogle Scholar
  328. Takeda N, Sakuragi N, Takeda M, Okamoto K, Kuwabara M, Negishi H et al (2002) Multivariate analysis of histopathologic prognostic factors for invasive cervical cancer treated with radical hysterectomy and systematic retroperitoneal lymphadenectomy. Acta Obstet Gynecol Scand 81(12):1144–1151 Epub 2003/01/10PubMedGoogle Scholar
  329. Takeshima N, Nishida H, Tabata T, Hirai Y, Hasumi K (2001) Positive peritoneal cytology in endometrial cancer: enhancement of other prognostic indicators. Gynecol Oncol 82(3):470–473PubMedGoogle Scholar
  330. Tan J, Chetty N, Kondalsamy-Chennakesavan S, Crandon A, Garrett A, Land R et al (2012) Validation of the FIGO 2009 staging system for carcinoma of the vulva. Int J Gynecol Cancer 22(3):498–502PubMedGoogle Scholar
  331. Tanaka Y, Sawada S, Murata T (1984) Relationship between lymph node metastases and prognosis in patients irradiated postoperatively for carcinoma of the uterine cervix. Acta Radiologica Oncology 23(6):455–459PubMedGoogle Scholar
  332. Tannock IF (1972) Oxygen diffusion and the distribution of cellular radiosensitivity in tumors. Br J Radiol 45:515–524PubMedGoogle Scholar
  333. Tantipalakorn C, Robertson G, Marsden DE, Gebski V, Hacker NF (2009) Outcome and patterns of recurrence for FIGO stages I and II squamous cell vulvar cancer. Obstet Gynecol 113(4):895–907PubMedGoogle Scholar
  334. Taylor MBDN, Davidson SE, Carrington BM (2007) Magnetic resonance imaging of primary vaginal carcinoma. Clin Radiol 62(6):549–555PubMedGoogle Scholar
  335. Tebeu PM, Popowski Y, Verkooijen HM, Bouchardy C, Ludicke F, Usel M et al (2004) Positive peritoneal cytology in early-stage endometrial cancer does not influence prognosis. Br J Cancer 91(4):720–724PubMedCentralPubMedGoogle Scholar
  336. Tewari D, Monk BJ, Al-Ghazi MS (2005) Gene expression profiling of in vitro radiation resistance in cervical carcinoma: a feasibility study. Gynecol Oncol 99:84–91PubMedGoogle Scholar
  337. Tewari KS, Filiaci VL, Spirtos NM, Mannel RS, Thigpen JT, Cibull ML et al (2012) Association of number of positive nodes and cervical stroma invasion with outcome of advanced endometrial cancer treated with chemotherapy or whole abdominal irradiation: a Gynecologic Oncology Group study. Gynecol Oncol 125(1):87–93PubMedGoogle Scholar
  338. Thomas G (2001) The effect of hemoglobin level on radiotherapy outcomes: the Canadian experience. Semin Oncol 28(S8):60–65PubMedGoogle Scholar
  339. Thomas GM, Dembo AJ, Myhr T, Black B, Pringle JF, Rawlings G (1993) Long-term results of concurrent radiation and chemotherapy for carcinoma of the cervix recurrent after surgery. Int J Gynecol Cancer 3(4):193–198Google Scholar
  340. Tjalma W, Weyler J, Weyn B (2000) The association between vascular endothelial growth factor and, microvessel density and clinicopathologic features in invasive cervical cancer. Eur J Obstet Gynecol 92:251–257Google Scholar
  341. Tran PT, Su Z, Lee P, Lavori P, Husain A, Teng N et al (2007) Prognostic factors for outcomes and complications for primary squamous cell carcinoma of the vagina treated with radiation. Gynecol Oncol 105(3):641–649 Epub 2007/03/17PubMedGoogle Scholar
  342. Tringler B, Grimm C, Dudek G, Zeillinger R, Tempfer C, Speiser P et al (2007) p16INK4a expression in invasive vulvar squamous cell carcinoma. Appl Immunohistochem Mol Morphol 15(3):279–283PubMedGoogle Scholar
  343. Tsai CS, Lai CH, Wang CC, Chang JT, Chang TC, Tseng CJ et al (1999) The prognostic factors for patients with early cervical cancer treated by radical hysterectomy and postoperative radiotherapy. Gynecol Oncol 75(3):328–333 Epub 1999/12/22PubMedGoogle Scholar
  344. Tsili AC, Tsampoulas C, Dalkalitsis N, Stefanou D, Paraskevaidis E, Efremidis SC (2008) Local staging of endometrial carcinoma: role of multidetector CT. Eur Radiol 18(5):1043–1048PubMedGoogle Scholar
  345. Urbanski K, Kojs Z, Reinfuss M, Fabisiak W (1996) Primary invasive vaginal carcinoma treated with radiotherapy: analysis of prognostic factors. Gynecol Oncol 60(1):16–21PubMedGoogle Scholar
  346. Valenzano M, Podesta M, Giannesi A, Corticelli A, Nicoletti L, Costantini S (2001) The role of transvaginal ultrasound and sonohysterography in the diagnosis and staging of endometrial adenocarcinoma. Radiol Med 101(5):365–370. Ecografia transvaginale e isterosonografia nella diagnosi e nella stadiazione dell’adenocarcinoma dell’endometrioGoogle Scholar
  347. van de Nieuwenhof HP, de Hullu JA, Kaanders JH, Bulten J, Massuger LF, van Kempen LC (2010) Hemoglobin level predicts outcome for vulvar cancer patients independent of GLUT-1 and CA-IX expression in tumor tissue. Virchows Arch 457(6):693–703PubMedCentralPubMedGoogle Scholar
  348. Van der Zee AG, Oonk MH, De Hullu JA, Ansink AC, Vergote I, Verheijen RH et al (2008) Sentinel node dissection is safe in the treatment of early-stage vulvar cancer. J Clin Oncol 26(6):884–889 Epub 2008/02/19PubMedGoogle Scholar
  349. Vavra N, Seifert M, Kucera H, Weghaupt K (1991) Radiotherapy of primary vaginal carcinoma and effects of histological and clinical factors on the prognosis. Strahlenther Onkol 167(1):1–6PubMedGoogle Scholar
  350. Viswanathan AN, Pinto AP, Schultz D, Berkowitz R, Crum CP (2013) Relationship of margin status and radiation dose to recurrence in post-operative vulvar carcinoma. Gynecol Oncol 130(3):545–549 Epub 2013/06/12PubMedGoogle Scholar
  351. van Bommel PF vLA, Kock HC, Leers WH, Neijt JP (1987). A review of prognostic factors in early-stage carcinoma of the cervix (FIGO I B and II A) and implications for treatment strategy. Eur J Obstet Gynecol Reprod Biol 26(1):69–84Google Scholar
  352. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV et al (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189(1):12–19 Epub 1999/08/19PubMedGoogle Scholar
  353. Wang CC, Lai CH, Huang HJ, Chao A, Chang CJ, Chang TC et al (2010) Clinical effect of human papillomavirus genotypes in patients with cervical cancer undergoing primary radiotherapy. Int J Radiat Oncol Biol Phys 78(4):1111–1120 Epub 2010/03/17PubMedGoogle Scholar
  354. Wang CC, Lai CH, Huang YT, Chao A, Chou HH, Hong JH (2012) HPV genotypes predict survival benefits from concurrent chemotherapy and radiation therapy in advanced squamous cell carcinoma of the cervix. Int J Radiat Oncol Biol Phys 84(4):e499–e506 Epub 2012/08/15PubMedGoogle Scholar
  355. Weinstock MA (1994) Malignant melanoma of the vulva and vagina in the United States: patterns of incidence and population-based estimates of survival. Am J Obstet Gynecol 171(5):1225–1230PubMedGoogle Scholar
  356. Werner HM, Trovik J, Marcickiewicz J, Tingulstad S, Staff AC, Amant F et al (2012) Revision of FIGO surgical staging in 2009 for endometrial cancer validates to improve risk stratification. Gynecol Oncol 125(1):103–108PubMedGoogle Scholar
  357. Whitney CWSW, Bundy BN, Malfetano JH, Hannigan EV, Fowler WC Jr, Clarke-Pearson DL, Liao SY (1999) Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study. J Clin Oncol 17:1339–1348PubMedGoogle Scholar
  358. Woelber L, Mahner S, Voelker K, Eulenburg CZ, Gieseking F, Choschzick M, Jaenicke, F Schwarz J (2009) Clinicopathological prognostic factors and patterns of recurrence in vulvar cancer. Anticancer Res 29(2):545–552Google Scholar
  359. Woelber L, Hess S, Bohlken H, Tennstedt P, Eulenburg C, Simon R et al (2012) EGFR gene copy number increase in vulvar carcinomas is linked with poor clinical outcome. J Clin Pathol 65(2):133–139PubMedGoogle Scholar
  360. Wong YF, Selvanayagam ZE, Wei N (2003) Expression genomis of cervical cancer: molecular classification and predicton of radiotherapy response by DNA microarray. Clin Cancer Res 9:5486–5492PubMedGoogle Scholar
  361. Wu X, Matanoski G, Chen VW, Saraiya M, Coughlin SS, King JB et al (2008) Descriptive epidemiology of vaginal cancer incidence and survival by race, ethnicity, and age in the United States. Cancer 113(10 Suppl):2873–2882PubMedGoogle Scholar
  362. Yamashita Y, Mizutani H, Torashima M, Takahashi M, Miyazaki K, Okamura H et al (1993a) Assessment of myometrial invasion by endometrial carcinoma: transvaginal sonography vs contrast-enhanced MR imaging. Am J Roentgenol 161(3):595–599Google Scholar
  363. Yamashita Y, Harada M, Sawada T, Takahashi M, Miyazaki K, Okamura H (1993b) Normal uterus and FIGO stage I endometrial carcinoma: dynamic gadolinium-enhanced MR imaging. Radiology 186(2):495–501PubMedGoogle Scholar
  364. Young P, Daniel B, Sommer G, Kim B, Herfkens R (2012) Intravaginal gel for staging of female pelvic cancers—preliminary report of safety, distention, and gel-mucosal contrast during magnetic resonance examination. J Comput Assist Tomogr 36(2):253–256PubMedGoogle Scholar
  365. Yuh WTC, Mayr NA, Jarjoura D, Wu DH, Grecula JC, Lo SS et al (2009) Predicting control of primary tumor and survival by DCE MRI during early therapy in cervical cancer. Invest Radiol 44:343–350PubMedCentralPubMedGoogle Scholar
  366. Zaino RJ, Kurman RJ, Brunetto VL, Morrow CP, Bentley RC, Cappellari JO et al (1998a) Villoglandular adenocarcinoma of the endometrium: a clinicopathologic study of 61 cases: a gynecologic oncology group study. Am J Surg Pathol 22(11):1379–1385PubMedGoogle Scholar
  367. Zaino RJ, Davis AT, Ohlsson-Wilhelm BM, Brunetto VL (1998b) DNA content is an independent prognostic indicator in endometrial adenocarcinoma. A Gynecologic Oncology Group study. Int J Gynecol Pathol 17(4):312–319PubMedGoogle Scholar
  368. Zighelboim I, Goodfellow PJ, Gao F, Gibb RK, Powell MA, Rader JS et al (2007) Microsatellite instability and epigenetic inactivation of MLH1 and outcome of patients with endometrial carcinomas of the endometrioid type. J Clin Oncol 25(15):2042–2048 Epub 2007/05/22PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2013

Authors and Affiliations

  • Melissa R. Young
    • 1
  • Susan A. Higgins
    • 1
  • William Yuh
    • 2
  • Nina A. Mayr
    • 3
  1. 1.Department of Therapeutic RadiologyYale University School of MedicineNew HavenUSA
  2. 2.Department of Diagnostic RadiologyUniversity of Washington School of MedicineSeattleUSA
  3. 3.Department of Radiation OncologyUniversity of Washington School of MedicineSeattleUSA

Personalised recommendations